Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000927016-02-003591
Filing Date
2002-07-10
Accepted
2002-07-10 12:09:11
Documents
2
Period of Report
2002-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.txt 6-K 2754
3 PRESS RELEASE dex99.txt EX-99 11108
  Complete submission text file 0000927016-02-003591.txt   15396
Mailing Address 28159 AVENUE STANFORD VALENCIA CA 91355
Business Address 5911 KJ VENLO SPOORSTRAAT P7 50 31-77-320-8400
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-28564 | Film No.: 02699540
SIC: 2836 Biological Products, (No Diagnostic Substances)